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ABSTRACT: Effective domestic wastewater treatment is
among our primary defenses against the dissemination of
infectious waterborne disease. However, reducing the amount
of energy used in treatment processes has become essential for
the future. One low-energy treatment option is anaerobic−
aerobic sequence (AAS) bioreactors, which use an anaerobic
pretreatment step (e.g., anaerobic hybrid reactors) to reduce
carbon levels, followed by some form of aerobic treatment.
Although AAS is common in warm climates, it is not known
how its compares to other treatment options relative to disease
transmission, including its influence on antibiotic resistance
(AR) in treated effluents. Here, we used metagenomic
approaches to contrast the fate of antibiotic-resistant genes
(ARG) in anaerobic, aerobic, and AAS bioreactors treating
domestic wastewater. Five reactor configurations were
monitored for 6 months, and treatment performance, energy use, and ARG abundance and diversity were compared in
influents and effluents. AAS and aerobic reactors were superior to anaerobic units in reducing ARG-like sequence abundances,
with effluent ARG levels of 29, 34, and 74 ppm (198 ppm influent), respectively. AAS and aerobic systems especially reduced
aminoglycoside, tetracycline, and β-lactam ARG levels relative to anaerobic units, although 63 persistent ARG subtypes were
detected in effluents from all systems (of 234 assessed). Sulfonamide and chloramphenicol ARG levels were largely unaffected by
treatment, whereas a broad shift from target-specific ARGs to ARGs associated with multi-drug resistance was seen across
influents and effluents. AAS reactors show promise for future applications because they can reduce more ARGs for less energy
(32% less energy here), but all three treatment options have limitations and need further study.
■ INTRODUCTION
Domestic biological wastewater treatment is among our most
effective defenses against the transmission of infectious
waterborne disease and poor water quality. Contemporary
wastewater treatment plants (WWTPs) effectively reduce waste
organic matter [as chemical oxygen demand (COD)], nitrogen
(N), and fecal bacterial levels,1 often employing aerobic
microbiological processes with active aeration [e.g., activated
sludge (AS)]. However, AS processes often have high operating
costs because of energy-consuming aeration, which will almost
certainly increase if energy prices rise in the future. This is a
worldwide concern, but it is especially problematic in emerging
countries, such as China and India, which have rapidly growing
economies, increased urbanization, chronic shortages of energy,
and higher baseline levels of endemic disease.
One possible energy-saving treatment option is anaerobic−
aerobic sequence (AAS) reactors, which pretreat the waste-
water anaerobically to reduce COD loads and potentially
produce biogas, followed by aerobic processes that polish the
anaerobic effluents to meet effluent discharge standards.
Dependent upon the design, AAS systems can have lower
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capital costs (relative to conventional treatment systems),
smaller footprints, lower sludge production, possible biogas
production, and reduced energy use because of lower oxygen
demand.1−4 In fact, AAS treatment systems are now quite
common for domestic waste treatment in warmer climate
regions (e.g., Brazil, Egypt, India, and Israel),5−7 although AAS
systems are not typical in temperate and colder parts of the
world.
Although a shift toward low-energy waste treatment has
become critical, treatment technologies must still protect
against disease transmission, such as reducing pathogen levels
in treated effluents. However, there is strong evidence that
WWTPs are reservoirs for and can promote antibiotic-resistant
bacteria (ARB) and antibiotic-resistant genes (ARG) in their
microbial communities,8−11 which then can be released to the
environment via liquid effluents and biosolids.8,12−15 The
increased potential for ARBs/ARGs in WWTPs has implica-
tions to all plants and their ability to protect against disease
because acquired antibiotic resistance (AR) in pathogenic and
other bacteria is increasing on a global scale.16 Therefore, for
low-energy waste treatment options to be implemented, they
must be at least as effective as current treatment approaches
(ideally better) in terms of ARG levels or they will not
effectively protect against resistant disease dissemination.
Here, we assessed ARG dissemination in the treated effluents
of three different domestic wastewater treatment options that
use different amounts of energy. Specifically, anaerobic, aerobic,
and AAS reactors treating domestic wastes were compared in
terms of energy use, treatment performance, and ARG
abundance and diversity over 6 months. High-throughput
sequencing and metagenomics were employed to characterize
ARG occurrence and diversity levels between influents and
effluents, which were compared to relative energy consumption
levels during treatment.
■ METHODS
Reactor Setup and Operations. Reactor configurations
are shown in Figure S1 of the Supporting Information). Fresh
settled wastewater was collected weekly from a local domestic
WWTP in northern England and stored in 18 L carboys at 4 °C
for use as reactor feeds. Mean waste influent characteristics
were as follows (±standard error): soluble COD (sCOD) =
265.9 ± 14.9 mg/L, total Kejdahl nitrogen (TKN) = 82.7 ±
8.41 mg of N/L, ammonia (NH3) = 47.2 ± 3.57 mg of N/L,
and pH = 7.2 ± 0.02. Wastewater was fed using peristaltic
pumps (Watson Marlow 520S, U.K.) directly into three initial
reactors, which included an upflow anaerobic sludge blanket
reactor (UASB), an anaerobic hybrid reactor (AHR), and a
completely mixed aerobic reactor (AER1); all reactor designs
used in domestic wastewater treatment.17 Effluents from the
AHR and UASB units were pumped into second-stage aerobic
units (AER2 and AER3) for further treatment, respectively (i.e.,
the two AAS systems were AHR−AER2 and UASB−AER3).
Two anaerobic reactor types were tested because a sub-goal was
to contrast UASB versus AHR designs relative to ARG/ARB
mitigation.
UASB and AHR reactors had working volumes of 1.5 L and
height/diameter ratios of 4.0 (H/D). Wastewater influent was
introduced at the bottom of the units, and both units were
operated at 3 day hydraulic retention times (HRTs).
Recirculation flow rates for the UASB and AHR reactors
were 133 and 155 mL/min, respectively. A three-phase
separator (gas−liquid−solid) was located at the top of each
reactor to reduce washout of suspended solids and also to trap
biogas in attached Tedlar sampling bags. The anaerobic units
were maintained at 35 ± 1 °C by circulating warm water
around their cores. pH was maintained between 6.8 and 7.2.
The three aerobic reactors had 1.04 L operating volumes.
Wastewater was fed by a peristaltic pump in the aerobic units,
either directly from the wastewater source (AER1) or from
AHR (AER2) or UASB (AER3) reactor effluent lines. The
aerobic reactors were operated at 2 day HRTs, which were
chosen based on preliminary system testing. No recycle was
provided because it was desired to keep operations simple to
minimize the chance of mechanical or other failures disturbing
the systems. Air supply was tightly regulated and monitored,
which was essential for energy calculations. Mixing was
provided using air diffusers, stir plates, and magnetic stir bars.
Aerobic reactors were maintained at room temperature (20−22
°C).
Sample Collection and Routine Sample Analysis.
Wastewater influent and effluent samples from the UASB,
AHR, and AER1 units and effluents from the two AAS systems
(UASB−AER2 and AHR−AER3) were collected and analyzed
weekly. These reactors were actually operated for over 6
months; however, sample collection for metagenomic analysis
was only performed over a 6 week window of time after the
reactors had been very stable for 6 weeks. Our goal was to
quantify ARG abundances and diversity under pseudo-steady-
state operating conditions. Routine monitoring included
sCOD, TKN, NH3, and pH for all units, total suspended
solids (TSS) and volatile suspended solids (VSS) for aerobic
units, and methane (CH4) production in the anaerobic units.
Influent and effluent samples for DNA extraction and
metagenomic analyses were collected weekly and frozen
immediately.
All chemical analyses were performed according to standard
methods for wastewater characterization,18 except biogas and
CH4 analysis. Gas bag volumes were recorded regularly, and
CH4 levels were quantified using direct injection into a Carlo
Erba 5160 (U.K.) Mega gas chromatograph (GC) equipped
with a flame ionization detector (FID) and a HP-PLOT Q
capillary column (30 m × 0.32 mm internal diameter) packed
with 20 μm Q phase. The GC oven temperature was
maintained at 35 °C, and the injector and detector were kept
at 300 °C. Hydrogen was used as the carrier gas (1 mL/min, 65
kPa). Methane analysis standards were prepared using a 70:30%
analytical-grade CH4/CO2 standard gas mixture (BOC Gases,
U.K.). All GC injections were performed in duplicate.
DNA Extraction, Sequencing, and Bioinformatic
Analysis. DNA was extracted from the weekly samples after
completion of all sampling, using the Fast Soil DNA extraction
kit (MP Biomedicals, Santa Ana, CA) and a Ribolyzer (MP
Biomedicals, Santa Ana, CA) according to instructions by the
manufacturer. After extraction, DNA were sorted and combined
into two tri-weekly groups for sequencing (i.e., the first 3 weeks
were combined, and the second 3 weeks were combined).
Combining DNA from sequential sampling windows provided
two independent samples for influent and effluent microbial
metacommunities in each reactor.
To assess the diversity and relative abundances of ARGs in
the combined samples, DNA extracts were provided (in
duplicate) to the Beijing Genomics Institute (BGI) for shotgun
library construction [insert size of 170 base pairs (bp)] and
high-throughput sequencing using the Illumina HiSeq 2000
platform. Approximately 3 Gb (giga base pairs) of data was
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generated for each DNA sample. Quality filtering was
conducted for all metagenomic data to ensure validity in
downstream analysis. Raw reads that contained three or more
ambiguous nucleotides, quality scores below 20 for more than
36 bases, or with adapter contamination were removed prior to
subsequent data processing. Quality-filtered metagenomic data
were searched for putative ARGs against the clean antibiotic
resistance database (ARDB), which had non-redundant
sequences using BLASTX with an E value of ≤10−5.19,20 A
read was identified as an ARG-like sequence according to its
best BLASTX hit with amino acid identity of ≥90% and
alignment length of ≥25 amino acids.21,22
Identified ARG-like sequences were sorted into ARG types
and subtypes, using a structured ARDB and customized python
script.20 ARG definitions, which included presumed resistance
mechanisms for each ARG, were based on previous work and
are simplifications because ARGs often code for proteins with
multiple effects.20,22 However, simplification is reasonable
because over 230 ARGs were assessed and overarching trends
were more important than individual details. To compare ARG
levels among samples, the number of ARG-like sequences was
normalized to the number of metagenome and ARG sequences
in each sample. As such, ARG levels are reported as either “total
metagenome sequences” (in ppm; one read in one million
reads) or “total ARG-like sequences” as percentages (%).
Energy Calculations. Energy use was calculated for all
systems, which included energy used for aeration, mixing,
heating, and pumping, and potential energy gained from biogas
production.2 To produce realistic energy estimates, calculations
for each case were based on extrapolated energy use in
geometrically identical, scaled-up treatment units treating 1000
L/day wastewater. However, the air supply rate, mixing, and
pumping rate data were based on measured lab reactor data.
Energy used in the aerated units was dominated by aeration
and mixing needs, which was calculated using measured air flow
rate data and equivalent paddle-mixing requirements for scaled-
up aerobic reactors. Power ratings for characteristic industrial-
scale centrifugal pumps were used to estimate feed and effluent
recycle pump energy needs.2 Energy estimates for anaerobic
units were based on the energy required for mixing as well as
the energy needed for heating anaerobic units to 35 °C.
Potential energy recovery from biogas production was
estimated based on previous CH4 data and the use of
industrial-scale gas turbines. Net energy used by the anaerobic
units was the difference between energy used for pumping,
heating, and mixing minus the potential energy gained from
biogas production. Energy calculations for AAS systems
included the energy used for mixing and aeration in the
aerobic units (less air was used because of lower sCODs) and
mixing, heating, and biogas production in the anaerobic units,
which varied slightly between the UASB and AHR reactors.
Other Data Analysis. This study contrasted aerobic,
anaerobic, and AAS treatment systems relative to ARG fate
and energy use using two independent influent and effluent
metagenomes per system (except AHR, where one metage-
nome was available; see Tables S1−S3 of the SI). However, to
allow for statistical comparisons among the three treatment
options, it was first necessary to determine whether ARG
characteristics between each duplicate pair were statistically the
same in paired DNA samples. One-way analysis of variation
(ANOVA) and t tests were performed on relative ARG levels in
each duplicate for the 19 AR groups (identified in the
metagenomic analysis; see Table S1 of the SI). If the duplicate
pairs were statistically the same (i.e., p < 0.05), data from the
duplicates were clumped as averages to allow for more rigorous
statistical comparisons among treatment opens. Follow-on tests
included two-sample testing, such as ANOVA among reactors
under each treatment, and statistical comparisons between
performance data for each reactor system. All analyses were
conducted using SPSS (version 17.0, Chicago, IL). The Venn
diagram was plotted using Venny (http://bioinfogp.cnb.csic.es/
tools/venny/), and the relatedness of influents and treated
effluents was visualized using Circos.23
■ RESULTS AND DISCUSSION
Bioreactor Performance, Operational Data, and
Energy Used Per Design. Two anaerobic (UASB and
AHR), one aerobic (AER1), and two AAS (AHR−AER2 and
UASB−AER3) treatment systems (see Figure S1 of the SI)
were monitored to compare treatment performance and ARG
metagenomes before and after treatment of domestic wastes.
Relative to treatment performance, Table 1 data show that
effluent sCOD, TKN, and NH3 levels did not significantly differ
between the two anaerobic reactors or between the two AAS
systems (p > 0.05). Therefore, these data were grouped under
“anaerobic” (UASB and AHR combined) and “AAS” (AHR−
Table 1. Treatment and Energy Performance Data for the Aerobic, Anaerobic, and AAS Treatment Units
effluents
parameter influent aerobic anaerobic AAS
pH 7.19 6.53 6.73 5.96
(0.05)a (0.12) (0.08) (0.15)
sCOD (mg/L) 167.0 22.7 34.8 7.58
(11.9) (5.42) (5.54) (1.37)
NH3 (mg/L) 58.9 3.22 17.3 5.84
(1.63) (1.47) (1.28) (0.77)
TKN (mg/L) 67.7 6.07 26.1 9.10
(4.79) (2.20) (2.98) (1.32)
TSS (mg/L) NDb 20.2 ND 26.8
(4.42) (10.3)
VSS (mg/L) ND 15.3 ND 19.3
(5.46) (11.9)
Energy use (KW/kg of sCOD removed) 1.9 from −0.4 to −0.7c from 1.2 to 1.4
aParentheses show 95% confidence intervals based on n = 12. bND = not done. cNegative values indicate energy gains in the anaerobic units per
COD removed.
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AER2 and UASB−AER3 combined), which were then
statistically compared to each other and the “aerobic” treatment
unit (AER1), relative to effluent sCOD, TKN, and NH3 levels.
The AAS systems had significantly lower effluent sCOD
levels than aerobic or anaerobic units alone (p < 0.027 and p <
0.002, respectively). In contrast, aerobic units had significantly
lower effluent TKN and NH3 levels than the AAS systems (p <
0.024 and p < 0.028, respectively), but the AAS systems had
significantly lower TKN and NH3 effluent levels than anaerobic
units alone (p < 0.002 and p < 0.002, respectively). Therefore,
sCOD and N removal levels were superior in the aerobic and
AAS systems to the anaerobic units alone, which is consistent
with past studies on aerobic and AAS systems in domestic
wastewater treatment, especially sCOD removals.3
AAS systems used ∼32% less energy (per kilogram of sCOD
removed) relative to the aerobic units (Table 1), largely
because of lower air use in the AAS aerobic units. Biogas
production itself (i.e., CH4) was low and erratic in both
anaerobic reactors, typically less than 10% CH4 in the gas
collectors. Therefore, potential energy gains from biogas
production were comparatively small in our AAS and anaerobic
systems (Table 1). In reality, low levels of biogas production is
a common problem in the anaerobic treatment of relatively
dilute domestic wastes3 and is partly why it is not used in many
places. Regardless, the AAS systems show promise because they
attain similar effluent quality to aerobic units, require less
energy, and produce far superior quality effluents to anaerobic
units. However, effluent ARG characteristics from AAS systems
must be determined relative to aerobic and anaerobic alone
systems.
Total Abundance of ARGs. Core ARG metagenomic data
for the reactors are summarized in Tables S1−S3 of the
Supporting Information. For statistical purposes, the absolute
number of detected ARG-like sequence reads were first
normalized to total metagenomic sequences to avoid bias
caused by different sequencing depths among the samples. On
the basis of normalized data (see Table S1 of the Supporting
Information), one-way ANOVA analysis of the three influent
samples (p = 0.82), the three anaerobic effluent samples (two
UASB and one AHR; p = 0.82), the four AAS effluent samples
(p = 0.86), and the two aerobic effluent samples (p = 0.84) was
performed and no statistically significant differences were seen
among samples within each grouping. As such, subsequent
analysis comparing influent and anaerobic, aerobic, and AAS
effluent metagenomes used grouped data to improve statistical
significance.
Normalized ARG abundances decreased through treatment
relative to influent ARG levels for all three treatment options
(see Figure 1A). The mean influent ARG abundance was 198
ppm, whereas anaerobic, aerobic, and AAS effluents had 74, 34,
and 29 ppm ARG abundances, respectively (62.6, 82.8, and
85.3% reductions); i.e., ARG abundances were over double in
anaerobic effluents compared to aerobic and AAS effluents.
However, Figure 1B also shows some ARG types proportionally
increased after treatment, including ARGs presumed to be
associated with multi-drug resistance, especially in the AAS and
aerobic effluents.
Results are generally consistent with previous work.10,12,24−27
Wastewater treatment can reduce apparent AR levels, although
removal efficiencies vary depending upon reactor design,
operating conditions, and ARG/ARBs assessed. Various
treatment systems have been assessed relative to ARG and
ARB fate, including AS, biofilters (BFs), and submerged aerated
filters (SAFs). Although it is hard to compare results from
different studies (because detection methods differ), general
observations are possible. As an example, the influence of plant
size and operating conditions was assessed on removal of
amoxicillin-, tetracycline-, and ciprofloxacin-resistant hetero-
trophic bacteria, enterobacteria, and enterococci.25 SAF and AS
systems efficiently reduced total bacteria, although removals did
not correlate with ARB removal rates in the systems. In
contrast, total bacterial removal rates were lower in BFs, which
displayed greater reductions in ARB levels relative to SAF and
AS designs.
Anaerobic treatment systems were a part of a large study of
northern Chinese WWTPs, which quantified blaNDM‑1 gene
levels across two full-scale treatment plants.10 The authors
found blaNDM‑1 gene numbers increased from the primary
clarifier through two biological treatment steps (anoxic and
then aerobic tanks in both WWTPs), confirming that ARG
abundances can increase in some unit operations. Interestingly,
only after biosolids were removed by secondary clarification did
blaNDM‑1 levels decline in their systems, implying that blaNDM‑1
is associated with the sludge biomass; i.e., genes are moving
with the biosolids, not necessarily being destroyed. Clearly,
treatment processes can either increase or decrease ARG and
ARB abundances relative to wastewater influents depending
upon the ARGs studied and treatment conditions.
ARG Diversity and Resistant Types among Reactor
Influent and Effluents. A total of 19 ARG types (see Tables
S1 and S2 of the Supporting Information) were assessed in
samples using metagenomics and deep sequencing methods,
which were further classified into ARG subtypes (see Table S3
Figure 1. Relative abundance of ARGs in the influent and effluent
samples. (A) Relative abundance of ARG-like sequences normalized to
the total number of reads in the metagenome. (B) Relative
percentages of different ARG types of the influent and effluent
samples. MLS denotes macrolide−lincosamide−streptogramin. Others
represents resistance genes that are not directly related to specific
antibiotic classes.
Environmental Science & Technology Article
DOI: 10.1021/es505521w
Environ. Sci. Technol. 2015, 49, 2577−2584
2580
of the Supporting Information). The most prominent ARG
types found in wastewater samples were tetracycline,
sulfonamide, multi-drug resistance, macrolide−lincosamide−
streptogramin (MLS), chloramphenicol, β-lactam, bacitracin,
aminoglycoside, and acriflavine (Figure 2). Overall abundances
of ARG sequences were lower in effluent versus influent
samples based on ARG sequence/absolute read data, although
percentage changes differed significantly between ARG type
and treatment conditions (see Table S2 of the Supporting
Information). A total of 17 of the 19 ARG types were detected
in influent samples, with dominant types being tetracycline
(39.7%), multi-drug (13.7%), bacitracin (12.3%), and then
MLS (10.8%) (see Table S2 of the Supporting Information).
Similarly, 17 of 19 ARG types were detected in anaerobic
effluents, with tetracycline (33.2%), aminoglycoside (20.1%), β-
lactam (13.5%), and multi-drug (8.2%) being dominant. In
contrast, only 13 ARG types were found in aerobic effluents,
with dominant ARGs being tetracycline (25.2%), multi-drug
(20.6%), aminoglycoside (14%), and sulfonamide (12.6%).
Finally, 16 ARG types were found in AAS effluents, with
tetracycline (16.8%), sulfonamide (11.6%), multi-drug (29.4%),
and bacitracin (13%) resistance being the most common.
Various observations are possible from Figures 1 and 2. First,
three ARG types were consistently higher in anaerobic effluents
relative to the AAS and aerobic effluents (in ppm): tetracycline,
aminoglycoside, and β-lactam sequences. This implies the ARG
types may more readily migrate through anaerobic versus
aerobic treatment processes, although there is no simple
mechanistic explanation for this phenomena. Second, neither
sulfonamide nor chloramphenicol ARGs were reduced by any
Figure 2. Distributions of ARG types in total annotated ARG sequences in the influent and effluents (anaerobic, aerobic, and anaerobic−aerobic).
The data were visualized using Circos.22 The length of the bars on the outer ring represented the percentage of ARGs in each sample (left side of the
diagram) and correlates the percentages of respective ARG types in the influent, aerobic, anaerobic, and anaerobic−aerobic samples (right side of the
diagram). MLS denotes macrolide−lincosamide−streptogramin. Others represents resistance genes that are not directly related to specific antibiotic
classes.
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treatment option, suggesting that ARGs for these antibiotics
may not be removed by any biotreatment process, which was
also seen in Swiss and Hong Kong WWTPs.20,28 Finally,
percentage levels of some ARG types were higher after
treatment, most noteworthy being multi-drug resistance
ARGs in aerobic and AAS effluents. Increases in multi-drug
resistance has been seen previously in WWTP processes,29 but
data here imply that relative increases may be greater in
processes that include aerobic steps. This observation is
consistent with data from Yang et al., who observed elevated
aminoglycoside, tetracycline, sulfonamide, and multi-drug
resistance ARGs in aerobic AS samples from the Shatin
WWTP in Hong Kong.20 Zhang et al. also detected elevated
tetracycline, macrolide, and multi-drug resistance ARG
sequences in mobile metagenome studies on AS, suggesting
that associated resistance determinants are on mobile genetic
elements (MGEs) within the wastes.22 Despite these
observations, it is key to note that observed increases are
percentage values based on many fewer ARG sequence reads in
effluent samples. Absolute levels of multi-drug resistance ARGs
actually declined in treated effluents relative to influent levels.
ARG Subtypes in the Different Reactor Effluents.
Although patterns of ARG transmission in different treated
effluents can be inferred from ARG type data, additional
information can be gained from ARG subtype data. Influent
samples had the highest abundance of ARG subtypes (219 of
234 ARG subtypes assessed) and reflected almost all ARG
subtypes seen in reactor effluents (Figure 3 and Table S3 of the
Supporting Information).30,31 The most abundant ARG
subtypes in the influent were related to tetracycline and
bacitracin, i.e., tetM (14 ppm), tetA(39) (12 ppm), tetW (12
ppm), tet32 (12 ppm), bacA (11 ppm), and uppP (11 ppm),
which are among the most common forms of resistance found
in the human gut and fecal DNA.32−34 In contrast, sul1, which
confers sulfonamide resistance, was abundant in all effluents
(2.4, 1.9, and 3.3 ppm in aerobic, AAS, and anaerobic effluents,
respectively). Other notable ARG subtypes seen in the effluents
were HAE1, the multi-drug efflux gene, found in aerobic (2.4
ppm) and AAS (2.1 ppm) effluents, tetA (5.2 ppm) in aerobic
effluents, and uppP (2.3 ppm) found in AAS effluent.
Tetracycline resistance gene tetV (21 ppm), aminoglycoside
2-N-acetyltransferase (12 ppm), and β-lactam-β-lactamase (8
ppm) were abundant in anaerobic effluents.
While subtype ARG abundances declined through treatment,
there were still 63 “persistent” ARG subtypes detected across
samples (including influents), which included 14 multi-drug
resistance, 10 aminoglycoside, 9 tetracycline, 7 MLS, and both
sulfonamide ARG subtypes (Figure 3). Disturbingly, these 63
subtypes accounted for 75, 98, 95, and 94% of the total relative
abundance of ARGs in the influent and aerobic, AAS, and
anaerobic effluents, respectively. Yang et al. similarly found 78
(of a total of 271) persistent subtypes in Shatin WWTP.35
Finally, only 14 influent ARG subtypes were found in the
effluents from aerobic or AAS processes, whereas 46 influent
ARGs were seen in effluents from anaerobic or AAS processes
(Figure 3). This suggests that the inclusion of an anaerobic step
in a treatment sequence may promote a greater number of
unique ARG subtypes than inclusion of aerobic steps.
ARG Resistance Mechanisms. Antibiotic resistance is
caused by four primary mechanisms: (1) efflux pumps, (2)
inactivation, (3) target bypass, and (4) target modification.36−43
The dominant resistance mechanisms observed in our influent
samples were efflux pump and target modification mechanisms
(∼38%; Figure 4). However, relative percentages of efflux
pump ARGs increased, and target modification ARGs declined
through all treatment options. As background, efflux pumps are
membrane-associated proteins that recognize and pump or
exclude antibiotics from the cell, reducing intracellular
antibiotic levels, which allows protein synthesis to proceed.39
Efflux pumps can either be specific for one compound (e.g., an
antibiotic) or can transport a wide range of chemically similar
compounds. Therefore, efflux pump systems often provide
defense against an array of inhibitory substances, including the
potential for conferring multi-drug resistance. Multi-drug efflux
proteins are generally encoded on the chromosome, while drug-
specific mechanisms are often encoded on MGE.39,41,42
Overall, Figure 4 data suggest that waste treatment selects
toward efflux and away from target modification resistance
mechanisms, especially in aerobic treatment processes (see
Tables S3−S5 of the Supporting Information). Given that
ARGs, which code for specific efflux pumps, are often found on
MGEs (see the Supporting Information for further discus-
sion),31,39,42,43 the presence of diverse chemical stressors in
waste treatment environments (e.g., heavy metals, disinfectants,
or other toxins) might favor the acquisition of multiple efflux
defense traits in their microbial communities. Gillings recently
Figure 3. Venn diagram of ARG subtypes found in the influent (INF)
and the effluents from the anaerobic (AN), aerobic (AER), and
anaerobic−aerobic sequence (AAS) reactors. These equate to 137
ARG subtypes in the effluents compared to 219 ARG subtypes found
in the wastewater influent.
Figure 4. Detected percentages of each resistance mechanism for the
influent and effluents from each treatment reactor condition. Other
represents mechanisms that are not directly related to specific
antibiotic classes.
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showed that bacterial stress can accelerate intracellular gene
rearrangement.44 Therefore, a shift away from specific-target
modification ARG sequences45 to both specific and multi-drug
efflux ARGs (and related mechanisms) might be expected in
waste treatment environments.46
Practical Implications. The practical question is “how do
such observations relate to potential implementation of lower
energy treatment technologies, such as AAS”. In reality, the
answer is not 100% clear. On the basis of results here, AAS and
aerobic treatment systems appear to be superior to anaerobic
alone processes relative to mitigating against ARG dissem-
ination. COD and N removal rates were also better in these
systems. However, results also show that AAS and aerobic
systems may select for proportionally greater levels of multi-
drug resistance.15,28,29 Therefore, no current treatment option
is perfect, and more work is needed at understanding how
resistance is transmitted in all treatment processes, not the least
of which is in biosolids,10 which was not addressed in this study.
In fact, reducing ARGs in biosolids processing may be where
work is most needed to reduce overall ARG releases from
WWTPs.
Our metagenomic data suggest that aerobic processes may be
generally better than anaerobic processes for reducing ARG
sequences through treatment and AAS can provide equivalent
treatment performance and ARG reduction for less energy
(∼32% here). Therefore, AAS reactors show considerable
promise for future waste treatment applications. However, all
treatment options have limitations, and work is needed to
understand ARG fate in waste treatment, especially ARGs
coding for potential multi-drug resistance in treated effluents.
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